欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/8002/001
药品名称Levomepromazine Morningside 25 mg Tabletten
活性成分
    • Levomepromazine maleate 25.0 mg
剂型Tablet
上市许可持有人Aspire Pharma (Malta) Limited Trident Park, Notabile Gardens No.2, Level 3, Mdina Road, Central Business District CBD 2010 BIRKIRKARA, Malta
参考成员国 - 产品名称Germany (DE)
Levomepromazine Morningside 25 mg Tabletten
互认成员国 - 产品名称
    • Denmark (DK)
      Levomepromazine Aspire
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Romania (RO)
许可日期2025/06/26
最近更新日期2025/06/26
药物ATC编码
    • N05AA02 levomepromazine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase